Shares of Zogenix , a small-cap pharmaceutical company with a focus on disorders of the central never system, fell hard during the month of September.
Was the sell-off justified? Read the short presentation below to get all of the details.
Continue Reading Below
The article Why Shares of Zogenix Inc Fell 26% in September originally appeared on Fool.com.
Brian Feroldi has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believeconsidering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright 1995 - 2015 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.